Lung Adenocarcinoma Systems Biomarker and Drug Candidates Identified by Machine Learning, Gene Expression Data, and Integrative Bioinformatics Pipeline
Lung adenocarcinoma (LUAD) is a significant planetary health challenge with its high
morbidity and mortality rate, not to mention the marked interindividual variability in treatment …
morbidity and mortality rate, not to mention the marked interindividual variability in treatment …
Copy number variations of stepwise-selected doxorubicin-resistant MCF-7 cell lines
HH Kazan, İS Acınan, B Kandemir, CP Karahan… - Gene, 2025 - Elsevier
Elimination of cytotoxic effect in cells with multidrug resistance (MDR) phenotype is a
situation that is gradually acquired over time and develops through multiple pathways …
situation that is gradually acquired over time and develops through multiple pathways …
Apoptosis-Mediated Anticancer Activity of Ganoderma colossus (Agaricomycetes) Extracts in Breast Cancer Cells
Cancer is a leading cause of death worldwide. The current cancer treatments including
chemo-, radio-and immuno-therapies pose various side effects, and chances of recurrence …
chemo-, radio-and immuno-therapies pose various side effects, and chances of recurrence …
Male Breast Cancer With Dual BRCA2 and BRIP1 Deleterious Gene Mutations
SB Badve, E Kim, US Sibia, OT Borrego, S Vara… - Ochsner …, 2024 - ochsnerjournal.org
Background: Male breast cancer remains relatively underexplored in the medical literature.
At present, male patients with breast cancer follow the same treatment guidelines as female …
At present, male patients with breast cancer follow the same treatment guidelines as female …
Gene expression in luminal A breast cancer and its correlation with chemoradiotherapy outcome and recurrence
J Ma, T Gan, A Song - International Journal of Radiation …, 2024 - search.proquest.com
Background: Breast cancer is a common cancer that affects women. The Luminal A subtype
of breast cancer is defined by low Ki67 expression (< 14%), Her-2 negative, and positive ER …
of breast cancer is defined by low Ki67 expression (< 14%), Her-2 negative, and positive ER …
[HTML][HTML] Synergistic Anticancer Efficacy of Curcumin and Doxorubicin Combination Treatment Inducing S-phase Cell Cycle Arrest in Triple-Negative Breast Cancer …
E Sarkar, A Khan, R Ahmad, A Misra, ST Raza… - Cureus, 2024 - pmc.ncbi.nlm.nih.gov
Background: Curcumin (Cur) is a polyphenol phyto-compound found in turmeric (Curcuma
longa) that inhibits tumorigenesis by introducing apoptosis and restricting cell survival and …
longa) that inhibits tumorigenesis by introducing apoptosis and restricting cell survival and …
Synergism of Curcumin and Doxorubicin Proves an Effective Anticancer Therapeutics Against Breast Cancer: An in vitro Study
Background: Curcumin is a polyphenol phyto-compound found in turmeric (Curcuma longa),
which inhibits tumorigenesis by introducing apoptosis as well as by restricting cell survival …
which inhibits tumorigenesis by introducing apoptosis as well as by restricting cell survival …